Back
 WJA  Vol.4 No.4 , December 2014
Vitamin D and Secondary Hyperparathyroidism in HIV Infected Patients Taking Antiretroviral Therapy
Abstract: Objective: Due to the lack of studies assessing hypovitaminosis D and secondary hyperparathyroidism in Brazilian HIV-infected population, especially in the northeastern population, this study aimed to determine the profile of these conditions in patients infected with HIV and its correlation with immuno-virological, sociodemographic data and associated comorbidities. Methods: Comparison studies were obtained from routine clinical samples of HIV infected patients submitted for 25-OH Vitamin D, PTH and alkaline phosphatase determination. Results: A total of 78 patients were included, 42 (53.8%) males, mean age 45.7 years. Antiretroviral regimens most used in this study were Zidovudine/Lamivudine/Efavirenz 17.9%, Tenofovir/Lamivudine/Efavirenz 17.9%,Tenofovir/Lamivudine/Atazanavir-r 15.4%. The mean value CD4 count was 592.1 ± 247.2 cells/mm3, CD8 cell count was 1026.5 ± 467.3 cells/mm3, mean detectable viral load was 2220 ± 15703 copies and CD4/CD8 ratio was 0.63 ± 0.33. A total of 34 vitamin D dosages were collected with 41.2% representing sufficient amount and 58.8% insufficient. Alkaline Phosphatase (ALP) dosage was elevated in 49.3% (N=35) of the patients. Parathormone (PTH) was elevated in 18% (N = 11). Among patients with elevated PTH levels, 81.9% had elevated levels of ALP (p = 0.01). In the group of patients with high levels of ALP, 45.7% had a CD4 count < 500 cels/mm3 (p = 0.02). There was no significant difference in vitamin D related to gender (p = 0.21), age (p = 0.23), CD4 count (p = 0.26), suppressed viral load (p = 0.44) or blood glucose (p = 0.45). Conclusions: This study evidenced a high prevalence of Vitamin D insufficiency in Northeast Brazil, which suggests HIV infection correlation. A high prevalence of Hyperparathyroidism was detected and related with inflammatory condition persistence and low CD4 count. We suggest improve vitamin D follow up and measurements in this population with better CD4 count control to avoid future osteoarticular complications of HIV treatment.
Cite this paper: Chaves, H. , Moreira, H. , Corrêa, H. , Machado, W. , Teles, R. , Nascimento, L. , Filho, J. , Queiroz, C. , Nóbrega, D. , Moreira, A. , Meneses, M. , Bezerra, F. , Medeiros, M. , (2014) Vitamin D and Secondary Hyperparathyroidism in HIV Infected Patients Taking Antiretroviral Therapy. World Journal of AIDS, 4, 430-437. doi: 10.4236/wja.2014.44051.
References

[1]   UNAIDS Global Report. AIDS Response Progress Reporting 2013. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva.

[2]   (2013) BoletimEpidemiológico-Aids e DST, Ministério da Saúde—Secretaria de Vigilancia em Saúde—Departamento de DST, Aids e Hepatites Virais.

[3]   Fisher, S.D., et al. (2011) Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients. American Journal of Cardiovascular Drugs, 11, 383-394. http://dx.doi.org/10.2165/11594590-000000000-00000

[4]   Butt, A.A., et al. (2009) HIV Infection and the Risk of Diabetes Mellitus. AIDS, 23, 1227-1234. http://dx.doi.org/10.1097/QAD.0b013e32832bd7af

[5]   O’Halloran, J.A., Satchell, C.S. and Mallon, P.W.G. (2013) Dyslipidemia, Atherosclerosis and Cardiovascular Disease: An Increasingly Important Triad in an Aging Population Living with HIV. Future Virology, 8, 1021-1034. http://dx.doi.org/10.2217/fvl.13.87

[6]   Duprez, D.A., et al. (2012) Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals. PLoS One, 7.

[7]   Fisher, S.D. and Lipshultz, S.E. (2011) Chapter 72: Cardiovascular Abnormalities in HIV-Infected Individuals. In: Bonow, R.O., et al., Eds., Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 9th Edition, Elsevier Saunders, Philadelphia, 1618-1627.

[8]   Brown, T.T. and Qaqish, R.B. (2006) Antiretroviral Therapy and the Prevalence of Osteopenia and Osteoporosis: A Meta-Analytic Review. AIDS, 20, 2165-2174.
http://dx.doi.org/10.1097/QAD.0b013e32801022eb

[9]   García Aparicio, A.M., et al. (2006) Abnormalities in the Bone Mineral Metabolism in HIV-Infected Patients. Clinical Rheumatology, 25, 537-539.

[10]   Schottker, B., Jorde, R., Peasey, A., et al. (2014) Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES). Vitamin D and Mortality: Meta-Analysis of Individual Participant Data from a Large Consortium of Cohort Studies from Europe and the United States. BMJ, 348.

[11]   Negredo, E., Puig, J., Bonjoch, A., Pérez-Alvárez, N., Echeverría, P., Estany, C., et al. (2012) Similarly High Prevalence of Hypovitaminosis D in HIV-Infected Subjects with and without Low Bone Mineral Density. Future Virology, 7, 1127-1134. http://dx.doi.org/10.2217/fvl.12.102

[12]   Mehta, S., Spiegelman, D., Aboud, S., Giovannucci, E.L., Msamanga, G.I., Hertzmark, E., et al. (2010) Lipid-Soluble Vitamins A, D, and E in HIV-Infected Pregnant Women in Tanzania. European Journal of Clinical Nutrition, 64, 808-817.

[13]   Connor, R.I. and Rigby, W.F. (1991) 1-Alpha, 25-Dihydroxyvitamin D3 Inhibits Productive Infection of Human Monocytes by HIV-1. Biochemical and Biophysical Research Communications, 176, 852-859.

[14]   Tafazoli, A. and Khalili, H. (2013) Vitamin D and HIV Infection: A Review of the Clinical Evidence. Future Virology, 8, 589-606. http://dx.doi.org/10.2217/fvl.13.40

[15]   Legeai, C., Vigouroux, C., Souberbielle, J.-C., Bouchaud, O., Boufassa, F., Bastard, J.-P., et al. (2013) Associations between 25-Hydroxyvitamin D and Immunologic, Metabolic, Inflammatory Markers in Treatment-Naive HIV-Infected Persons: The ANRS CO9 “COPANA” Cohort Study. PLoS ONE, 8, e74868.

[16]   Wasserman, P. and Rubin, D.S. (2010) Highly Prevalent Vitamin D Deficiency and Insufficiency in an Urban Cohort of HIV-Infected Men under Care. AIDS Patient Care STDS, 24, 223-227.
http://dx.doi.org/10.1089/apc.2009.0241

[17]   Conrado, T., Miranda-Filho, D.B. and Bandeira, F. (2010) Vitamin D Deficiency in HIV-Infected Individuals: One More Risk Factor for Bone Loss and Cardiovascular Disease? Arquivos Brasileiros de Endocrinologia e Metabologia, 54, 118-122.

[18]   Rodríguez, M., Daniels, B., Gunawardene, S. and Robbins, G.K. (2009) High Frequency of Vitamin D Deficiency in Ambulatory HIV-Positive Patients. AIDS Research and Human Retroviruses, 25, 9-14.

[19]   Dao, C.N., Patel, P., Overton, E.T., Rhame, F., Pals, S.L., Johnson, C., et al. (2011) Low Vitamin D among HIV Infected Adults: Prevalence of and Risk Factors for Low Vitamin D Levels in a Cohort of HIV Infected Adults and Comparison to Prevalence among Adults in the US General Population. Clinical Infectious Diseases, 52, 396-405.

[20]   Stein, E.M., Yin, M.T., McMahon, D.J., Shu, A., Zhang, C.A., Ferris, D.C., et al. (2011) Vitamin D Deficiency in HIV-Infected Postmenopausal Hispanic and African-American Women. Osteoporosis International, 22, 477-487. http://dx.doi.org/10.1007/s00198-010-1299-x

[21]   Adeyemi, O.M., Agniel, D., French, A.L., Tien, P.C., Weber, K., Glesby, M.J., et al. (2011) Vitamin D Deficiency in HIV-Infected and HIV-Uninfected Women in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 57, 197-204.

[22]   Cervero, M., Agud, J.L., García-Lacalle, C., Alcázar, V., Torres, R., Jusdado, J.J. and Moreno, G.S. (2012) Prevalence of Vitamin D Deficiency and Itsrelated Risk Factor in a Spanish Cohort of Adult HIV-Infected Patients: Effects of Antiretroviral Therapy. AIDS Research and Human Retroviruses, 28, 963-971.

[23]   Sudfeld, C.R., Wang, M., Aboud, S., Giovannucci, E.L., Mugusi, F.M. and Fawzi, W.W. (2012) Vitamin D and HIV Progression among Tanzanian Adults Initiating Antiretroviral Therapy. PLoS ONE, 7, e40036.

[24]   Mansky K.C. (2010) Aging, Human Immunodeficiency Virus, and Bone Health. Clinical Interventions in Aging, 5, 285-292.

[25]   Ansemant, T., Mahy, S., Piroth, C., Ornetti, P., Ewing, S., Guilland, J.-C., et al. (2013) Severe Hypovitaminosis D Correlates with Increased Inflammatory Markers in HIV Infected Patients. BMC Infectious Diseases, 13, 7. http://dx.doi.org/10.1186/1471-2334-13-7

[26]   Conesa-Botella, A., Florence, E., Lynen, L., Colebunders, R., Menten, J. and Moreno-Reyes, R. (2010) Decrease of Vitamin D Concentration in Patients with HIV Infection on a Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimen. AIDS Research and Therapy, 7, 40-45.
http://dx.doi.org/10.1186/1742-6405-7-40

[27]   Klassen, K., Martineau, A.R., Wilkinson, R.J., Cooke, G., Courtney, A.P. and Hickson, M. (2012) The Effect of Tenofovir on Vitamin D Metabolism in HIV-Infected Adults Is Dependent on Sex and Ethnicity. PLoS ONE, 7, e44845.

[28]   Van Vonderen, M.G.A., Lips, P., van Agtmael, M.A., Hassink, E.A.M., Brinkman, K., Geerlings, S.E., et al. (2009) First Line Zidovudine/Lamivudine/Lopinavir/Ritonavir Leads to Greater Bone Loss Compared to Nevirapine/Lopinavir/Ritonavir. AIDS, 23, 1367-1376.
http://dx.doi.org/10.1097/QAD.0b013e32832c4947

[29]   Holick, M.F. et al. (2011) Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 96, 1911-1930.

[30]   Villamor, E. (2006) A Potential Role for Vitamin D on HIV Infection? Nutrition Reviews, 64, 226-233.

[31]   Conrado, T., Miranda-Filho, D.B., Ximenes, R.A.A., Albuquerque, M.F., Lacerda, H.R., Ramos, R.C.F., et al. (2011) Vitamin D Deficiency in HIV-Infected Women on Antiretroviral Therapy Living in the Tropics. Journal of the International Association of Physicians in AIDS Care, 10, 239-245.
http://dx.doi.org/10.1177/1545109711399657

[32]   Daeson-Hughes, B., Harris, S.S., Krall, E.A. and Dallal, G.E. (1997) Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older. New England Journal of Medicine, 337, 670-676. http://dx.doi.org/10.1056/NEJM199709043371003

[33]   Evatt, M.L., Delong, M.R., Khazai, N., Rosen, A., Triche, S. and Tangpricha, V. (2008) Prevalence of Vitamin D Insufficiency in Patients with Parkinson Disease and Alzheimer Disease. Archives of Neurology, 65, 1348-1352. http://dx.doi.org/10.1001/archneur.65.10.1348

[34]   Pittas, A.G., Dawson-Hughes, B., Li, T., Van Dam, R.M., Willett, W.C., Manson, J.E. and Hu, F.B. (2006) Vitamin D and Calcium Intake in Relation to Type 2 Diabetes in Women. Diabetes Care, 29, 650-656. http://dx.doi.org/10.2337/diacare.29.03.06.dc05-1961

[35]   Pérez-López, F.R. (2009) Vitamin D Metabolism and Cardiovascular Risk Factors in Postmenopausal Women. Maturitas, 62, 248-262. http://dx.doi.org/10.1016/j.maturitas.2008.12.020

[36]   Giovannucci, E., Liu, Y., Rimm, E.B., Hollis, B.W., Fuchs, C.S., Stampfer, M.J. and Willett, W.C. (2006) Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men. Journal of the National Cancer Institute, 98, 451-459. http://dx.doi.org/10.1093/jnci/djj101

[37]   Canale, D., de Bragan?a, A.C., Gon?alves, J.G., Shimizu, M.H.M., Sanches, T.R., Andrade, L., et al. (2014) Vitamin D Deficiency Aggravates Nephrotoxicity, Hypertension and Dyslipidemia Caused by Tenofovir: Role of Oxidative Stress and Renin-Angiotensin System. PLoS ONE, 9, e103055.

[38]   Blayney, M.J., Pisoni, R.L., Bragg-Gresham, J.L., Bommer, J., Piera, L., Saito, A., et al. (2008) High Alkaline Phosphatase Levels in Hemodialysis Patients Are Associated with Higher Risk of Hospitalization and Death. Kidney International, 74, 655-663.

[39]   Overton, E.T. and Yin, M.T. (2011) The Rapidly Evolving Research on Vitamin D among HIV-Infected Populations. Current Infectious Disease Reports, 13, 83-93.

 
 
Top